Nabumetone Tablet
Product Images NDC 50228-466

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 50228-466). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sciegen Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container1 (Container1)

Nabumetone Tablets, USP 500 mg oral tablets label from ScieGen Pharmaceuticals Inc. The label indicates the strength as 500 mg, container count of 100 tablets, and Rx only status. Storage instructions specify 20°C to 25°C with permitted excursions. The label includes dispensing and child safety instructions, the manufacturer address, and a barcode.*

FDA Label Image

Container2 (Container2)

Label for Nabumetone Tablets, USP 500 mg oral tablets, manufactured by ScieGen Pharmaceuticals Inc. The label indicates a package containing 500 tablets, with storage instructions and prescription-only status. The label also mentions dispensing a Medication Guide with each patient and includes the NDC number 50228-465-05.*

FDA Label Image

Container2 (Container3)

Label for Nabumetone Tablets USP 750 mg oral tablets by ScieGen Pharmaceuticals Inc. The package contains 100 tablets. It includes storage instructions, dosage reference, and a barcode. The label states the NDC 50228-466-01 and includes a note to dispense the accompanying Medication Guide.*

FDA Label Image

Container2 (Container4)

Nabumetone Tablets, USP 750 mg oral tablet label from ScieGen Pharmaceuticals Inc. The label indicates a package of 500 tablets with storage instructions, dosage guidance, and child-resistant container requirement. It includes the NDC 50228-466-05 and a barcode.*

FDA Label Image

Figure1 (Figure1)

A line graph showing Nabumetone active metabolite (6MNA) plasma concentrations over time (hours) at steady state following once-daily dosing of Nabumetone at 1000 mg and 2000 mg. The y-axis represents concentration (ng/mL), and the x-axis represents time in hours up to 70. The graph includes curves for average concentrations with ±2 standard deviations for each dose group.*

FDA Label Image

Structure1 (Structure1)

Chemical structure of Nabumetone, showing its molecular formula C15H16O2 and molecular weight 228.3. The diagram depicts the arrangement of atoms including methoxy and ketone functional groups.*

FDA Label Image

Structure2 (Structure2)

Chemical structure of 6-methoxy-2-naphthylacetic acid (6MNA), the active metabolite of Nabumetone, showing the molecular arrangement of carbon, hydrogen, and oxygen atoms in the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.